Dynavax: On Troubled Waters [Seeking Alpha]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Seeking Alpha
Dynavax: On Troubled Waters A year ago, in an article DVAX dubitante. Dynavax's Q2, 2019 HEPLISAV-B report was constructive. Dynavax reported its Q2, 2019 results on 8/7/19. It reported solid sales for its one FDA approved therapy, HEPLISAV-B, of $8.3 million. The company launched Since that inaugural quarter of minimal HEPLISAV-B sales, it has managed to bump sales up incrementally quarter by quarter to Q2, 2019's aforesaid $8.3 million. There is definitely a market for the product, and it might even be a viable market for the right company. However, Dynavax may not be that company. Until its recent reorganization, Dynavax was laboring under the mistaken assumption that HEPLISAV-B revenues could support not only its own costs but also those of a parallel immuno-oncology (I-O) program. In May 2019, after apparently realizing that it was biting off more than it could chew, the company announced that it was "exploring strategic alternatives" for its I-O therapies. Accordingly, HEPLISAV-
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Global Human Vaccines Market (2023-2028) [Yahoo! Finance]Yahoo! Finance
- Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]Yahoo! Finance
- Dynavax Technologies: Still A Believer [Seeking Alpha]Seeking Alpha
- Dynavax: Holding Firm Despite Its Missing Cash Cow [Seeking Alpha]Seeking Alpha
DVAX
Earnings
- 2/22/24 - Beat
DVAX
Sec Filings
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- DVAX's page on the SEC website